Merck Sends Assistance to Flood-Ravaged Thailand

Merck KGaAMerck KGaA and its Life Science division Merck Millipore have sent thousands of state-of-the-art water test kits to Thailand in an effort to ensure the safety of municipal drinking water following months of devastating flooding in that region. In addition to the product shipment, the company has donated €110,000 to assist flood victims.

"Safe drinking water is a basic human right," said Robert Yates, Head of Merck Millipore. "When it became apparent that public drinking water might be impacted by the floods, we did not hesitate to send our test kits. It is our collective hope that in some small way Merck can help the people of Thailand recover from these devastating floods."

The Merck Millipore division has shipped more than 10,000 test kit elements that will be distributed to various Thai organizations, including the National Metal and Materials Technology Center (MTEC), a member of National Science and Technology Development Agency (NSTDA); the Ministry of Science and Technology; and the Samsen office of the Metropolitan Waterworks Authority. The test kits will be used to detect any evidence of contamination in the drinking water.

"The floods have carried dirt and potential contaminants into the raw water system, creating public concern about the safety of the water," said Klaus Bischoff, Head of Merck Millipore's Lab Solutions business unit. “The high-quality water analysis products we have donated will help the local authorities monitor the water quality and bring peace of mind to the community.”

In addition to the product donation, Merck has donated €110,000 to assist flood victims in the region. The donation is earmarked for flood evacuation efforts, as well as to provide temporary housing and filtered water to impacted employees and the general public in the hardest hit areas of Thailand.

About Merck KGaA
Merck is a global pharmaceutical and chemical company with total revenues of € 9.3 billion in 2010, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...